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Structure of the IRS-1 PTB Domain
Bound to the Juxtamembrane Region
of the Insulin Receptor
Michael J. Eck,*³ Sirano Dhe-Paganon,²³ 1995). A second substrate of the insulin receptor,
Thomas TruÈ b,²³ Robert T. Nolte,*³ IRS-2, has a similar domain structure and functions anal-
and Steven E. Shoelson²³ ogously in signaling (Sun et al., 1995).
*Laboratory of Molecular Medicine A PTB or PI (phosphotyrosine interaction) domain has
Children's Hospital been identified independently in Shc, a substrate of nu-
²Research Division merous receptor-linked tyrosine kinases, including the
Joslin Diabetes Center insulin receptor (Blaikie et al., 1994; Kavanaugh and
³Department of Medicine Williams, 1994; van der Geer et al., 1995). The Shc PTB
Harvard Medical School domain also binds an ªNPXpYº or related motif, and it
Boston, Massachusetts 02115 requires a hydrophobic residue at pY25 (Dikic et al.,
1995; TruÈ b et al., 1995). Several proteins have homology
with the Shc PTB domain (Bork and Margolis, 1995),
Summary including at least one reported to bind protein (Fiore et
al., 1995). Nonetheless, the Shc PTB domain shares
Crystal structures of the insulin receptor substrate-1 no recognizable sequence similarity either with the IRS
(IRS-1) phosphotyrosine-binding (PTB) domain, alone domains or with SH2 domains.
and complexed with the juxtamembrane region of the We have determined X-ray crystal structures of the
insulin receptor, show how this domain recognizes IRS-1 PTB domain, alone and in complex with a phos-
phosphorylated ªNPXYº sequence motifs. The domain phopeptide sequence corresponding to its site of in-
is a 7-stranded b sandwich capped by a C-terminal teraction with the insulin receptor. The domain is a
helix. The insulin receptor phosphopeptide fills an 7-stranded b sandwich capped by a long a helix. It
L-shaped cleft on the domain. The N-terminal residues closely resembles a PH domain. All nine residues of the
of the bound peptide form an additional strand in the Ac-LYASSNPApY-NH2 peptide contact the IRS-1 PTB
b sandwich, stabilized by contacts with the C-terminal domain. The phosphotyrosine interacts extensively with
helix. These interactions explain why IRS-1 binds to two arginines. The NPXpY motif of the peptide forms a
the insulin receptor but not to NPXpY motifs in growth type I b turn, which lies on a platform created by a 310
factor receptors. The PTB domains of IRS-1 and Shc turn between strands b4 and b5 of the domain. The
share a common fold with pleckstrin homology do- asparagine at pY23 appears to be essential for binding,
mains. Overall, ligand binding by IRS-1 and Shc PTB as its side chain forms both intrapeptide and intermolec-
domains is similar, but residues critical for phospho- ular hydrogen bonds. Peptide residues pY23 to pY28
tyrosine recognition are not conserved. lie in a groove parallel to the helix and to strand b5, and
create an additional strand on the domain b sandwich.
A recent multidimensional nuclear magnetic reso-
Introduction nance study has revealed a related structure for the
Shc PTB domain (Zhou et al., 1995), and the general
Activated insulin receptor initiates signal transduction orientations for peptide binding to the two PTB domains
by phosphorylating its own intracellular b subunits as are similar. However, the residues that contact the phos-
well as additional cellular proteins. Insulin receptor sub- photyrosine are different in the twodomains. One critical
strate-1 (IRS-1) is the best studied of these additional arginine in the Shc domain lies in a long insertion be-
substrates. It serves as a link between the activated tween strands b1 and b2 that is not present in IRS-1.
receptor and numerous effector proteins that bear Src The domain surface used by the IRS-1 PTB domain in
homology-2 (SH2) domains (Sun et al., 1991, 1993). The phosphopeptide binding is also different from the one
first steps in signaling involve autoactivation of the re- used by PH domains to bind phosphoinositides (Fergu-
ceptor by phosphorylation of tyrosines 1146, 1150, and son et al., 1995; HyvoÈ nen et al., 1995). Therefore, the
1151 in its catalytic cleft (White et al., 1988b; Hubbard IRS-1 and Shc PTB domains and PH domains share
et al., 1994), and phosphorylation of tyrosine 960 in its similar folds, but they have evolved distinct mechanisms
juxtamembrane region. The latter phosphorylation leads for phospholigand recognition.
to recruitment of IRS-1 (White et al., 1988a; O'Neill et
al., 1994). At least two regions of the IRS-1 protein are
necessary for efficient interaction with the activated re-
Results and Discussionceptor: a pleckstrin homology (PH) domain at the ex-
treme N-terminus (Myers et al., 1995; Voliovitch et al.,
Delineating and Crystallizing the PTB Domain1995) and a domain just C-terminal to it (Wolf et al.,
Sequence alignments between IRS-1 and IRS-2 reveal1995). We have termed this second region the IRS-1
two regions of extended homology, termed IH-1 andphosphotyrosine-binding (PTB) domain. The receptor
IH-2 (IRS-1 homology 1 and 2) (Sun et al., 1995). Thesequence N-terminal to tyrosine 960 is also important
first is predicted to be a PH domain (Musacchio et al.,for the interaction. In vitro binding experiments show
1993). The second does not align readily with knownthat the IRS-1 PTB domain recognizes phosphotyrosine
protein sequences in data bases. In a previous study,in the context of an NPXpY sequence motif with a hy-
drophobic residue at pY28 (He et al., 1995; Wolf et al., the entire 173-residue IH-2 domain of human IRS-1 was
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Figure 1. Functional Mapping of the IRS-1 PTB Domain and Structure-Based Sequence Alignments of PTB and PH Domains
(A) Domain structure of IRS-1 and phosphopeptide binding activity of expressed proteins. IRS-1 contains a PH domain and a second homology
domain (termed IH-2) having PTB domain activity. Serial truncations at both ends of the IH-2 domain show that PTB activity is preserved with
significantly shorter proteins and suggest that residues 162±267 encompass a fully active domain, consistent with the stably folded domain
(161±265) observed in our crystal structure. (asterisk) ND, not determined; rapid proteolysis of 172±316 in E. coli suggests that it is not stably
folded.
(B) Structure-based sequence alignments between IRS and Shc PTB domains and several PH domains. Sequences of human IRS-1 (161±265)
and Shc (40±210) PTB domains, and rat phospholipase Cd (11±140), human N-terminal pleckstrin (1±103), human dynamin (506±629), and
mouse brain spectrin (2199±2304) PH domains, were aligned by superimposing the structures. Numbers refer to human IRS-1. a helices are
boxed in turquoise, b-sheet strands in green, and critical arginines for phosphotyrosine recognition are boxed in red. Arrowheads denote
residues involved in ligand binding: red for pY binding, gray for residues of IRS-1 interacting with insulin receptor sites other than pY, and
blue for residues of PLCd and spectrin PH domains that bind phosphoinositide polyphosphate.
expressed in Escherichia coli and found to possess PTB domain, a segment considerably shorter than the 173
residues identified by sequence alignment, but remark-activity (Wolf et al., 1995). For crystallographic studies,
additional truncated versions were expressed to delimit ably consistent with the ordered region observed in our
crystal structure (161±265). The protein used for crystal-boundaries of the PTB domain (Figure 1A). Phosphopro-
tein binding was retained following removal of residues lization included residues 144±267 of IRS-1, and two
additional residues (Gly±Ser) at the amino terminus. Thisfrom both amino and carboxyl ends of the homology
region. These truncation data suggest that residues fragment was generated by thrombin proteolysis of a
glutathione S-transferase (GST) IRS-1 144±316 fusion162±267 constitute a stably folded and functional PTB
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protein. The cleaved protein retained full PTB function Arg-227, which extend from the b5 and b6 strands, re-
spectively (Figures 1B and 5B).and crystallized in the presence and absence of its natu-
ral ligand, the juxtamembrane region of the insulin re- In addition to b sheet (backbone) interactions, there
are numerous contacts between thedomain and peptideceptor.
The 9-residue peptide ligand in our crystals has the side chains that contribute specificity to the interaction.
The leucine at pY28 is important for high affinity bindingsequence Leu-Tyr-Ala-Ser-Ser-Asn-Pro-Ala-pTyr, which
corresponds to receptor residues 952±960, with alanine to the insulin receptor (Gustafson et al., 1995; Wolf et
al., 1995). It is bound in a shallow hydrophobic pocketrather than glutamic acid at position pY21. The alanine
substitution increases binding affinity 30-fold (Wolf et between Phe-222 and Trp-237 (Figures3Aand 4B).Tyro-
sine at pY27 is largely solvent exposed, but it is in vanal., 1995).
der Waals contact with His-216. The side chain of the
pY26 residue, an alanine in the IR peptide, extends
Structure of the Domain toward Phe-222 and Arg-212 onthe domain, and leucine
The IRS-1 PTB domain is a compact 7-stranded b sand-
wich, capped on one end by a long a helix. This fold is
also found in PH domains, a protein module found in
many signal transduction proteins. To facilitate compari-
sons with this structurally related domain, the same no-
menclature used for elements of secondary structure in
PH domains has been applied to the PTB domain. A
ribbon diagram showing the arrangement of secondary
structural elements and the position of the bound phos-
phopeptide is shown in Figure 2A. One face of the b
sandwich is formed by b1-b4, arranged in an antiparallel
b sheet. Strands b1 and b2 are long and curved, wrap-
ping around to contribute to the b5-b7 face. The poly-
peptide segment connecting strands b1 and b2 forms
1 1/2 turns of an a helix, which partially ªcapsº the
bottom of the b sandwich. The connections between
the other b strands and between b7 and the C-terminal
helix are rather short, giving the domain its compact
appearance. A 310 helical turn connects strands b4 and
b5, a feature of the PTB domain that may be important
for recognition of phosphorylated NPXpY peptides (see
below).
The free and complexed domains are superimposed
in Figure 2B. The structures deviate most in the loop
connecting strands b3 and b4, a region that is poorly
ordered in the apodomain. The carboxy-terminal helix
is a full turn longer in the liganded structure, likely due
tostabilization of the helix by interactionswith the bound
phosphopeptide. The penultimate turn of the helix (resi-
dues 257±261), which interacts directly with the Asn-
Pro-Ala turn in the complexed peptide, is poorly ordered
in the unliganded structure.
Peptide Recognition
The insulin receptor phosphopeptide fills an L-shaped
cleft on the surface of the PTB domain (Figures 2A and
Figure 2. Structure of the Free and Complexed IRS-1 PTB Domains3A). The recognition site is formed by the b5 strand, the
(A) RIBBONS (Carson, 1991) diagram showing the fold of theC-terminal helix, and the 310 turn connecting strands b4
IRS-1 PTB domain and the orientation of the bound insulin receptorand b5. The entire 9-residue peptide is in contact with
peptide. The IRS-1 domain is a compact 7- stranded b sandwich
the domain; the interaction buries 779 AÊ 2 of surface area. (green) closed on top by helix a2 (turquoise). A short helix (a1) and
The amino-terminal residues of the peptide (pY28 to its connecting loops partially cap the bottom of the sandwich. A 310
helical turn (deep blue) connects strands b4 and b5 and forms part ofpY23) form a b strand that hydrogen bonds to strand b5
the binding site for residues 952±960 of the insulin receptor peptidein an antiparallel orientation (Figure 4A). The C-terminal
(shown in stick representation).residues of the peptide NPApY form a type I b turn,
(B) Superposition of free and complexed IRS-1 PTB domains. Cawhich positions the phosphotyrosine residue so that it
tracings of the bound (orange) and free (green) PTB domains show
extends at a 908 angle from the amino-terminal peptide minimal differences other than an extension of the helix in the pres-
backbone (Figures 4B). The phosphotyrosine is coordi- ence of bound peptide. Ca atoms of core residues of the structures
superimpose with an RMS deviation of 0.29 AÊ .nated primarily by two arginine residues, Arg-212 and
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Figure 3. Comparisons of PTB and PH Domains
Molecular surface representation of (A) the IRS-1 PTB domain and (B) the phospholipase Cd PH domain (Ferguson et al., 1995), shown roughly
in the same orientation as in Figure 2. The molecular surfaces were calculated and shaded according to electrostatic potential (25kt/e, red
to 17kt/e, blue) using the program GRASP (Nicholls et al., 1991). (A) The insulin receptor peptide (gray) fills an L-shaped cleft on the surface
of the PTB domain. The binding surface is largely uncharged outside of the phosphotyrosine-binding pocket. (B) Inositol 1,4,5-trisphosphate
(red) binds in the center of a large positively charged region at the base of the PH domain. This electrostatic polarization is a feature of all
PH domains of known structure but is not observed in the IRS-1 PTB domain. (C) Divergent recognition of phosphotyrosine by IRS-1 and Shc
PTB domains. Ca tracings of the IRS-1 (left) and Shc (right) PTB domains are shown. Key residues involved in phosphotyrosine coordination
(yellow balls) are in similar spatial positions, yet arise from different regions in the primary sequences and distinct elements of secondary
structure. (D) PTB and PH domains share a common fold. Ca carbons of the phospholipase Cd (green), dynamin (blue), and spectrin (red) PH
domains are superimposed on the IRS-1 PTB domain (yellow). For clarity, selected loops from the PH domains have been omitted. Ca atoms
of these core residues superimpose with an RMS deviation of z1.0 AÊ .
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(pY28) on the peptide. Serine, the pY25 residue, forms from our structure why IRS-1 does not bind to growth
factor receptors. This discrimination may in turn explaina hydrogen bond with His-250 on the carboxy-terminal
helix of the domain, and it is also packed against Leu- why growth factor receptors do not phosphorylate
IRS-1. The hydroxyl group of serine at pY24 extends254 in the next turn of the helix. Bulky hydrophobic side
chains are present at pY25 in the optimal Shc PTB away from the surface of the domain.
A common consensus motif NPXpY appears in sitesdomain recognition motifs found in growth factor recep-
tors and transforming proteins (Dikic et al., 1995; Kava- recognized by both IRS-1 and Shc PTB domains, sug-
gesting that the sequence and conformation of posi-naugh et al., 1995; TruÈ b et al., 1995; Wolf et al., 1995).
There is insufficient space in the IRS-1 PTB domain tions pY23, pY22, and pY21 are particularly critical for
binding. In our structure, these residues adopt a type Icomplex to accommodate large, hydrophobic side
chains at peptide position pY25. It is therefore clear b-turn conformation, thereby defining the overall shape
of the bound peptide (Figures 2A and 5B). In addition,
they interact extensively with the protein. Asparagine is
particularly critical. Its side chain oxygen accepts an
intrapeptide hydrogen bond from the amide nitrogen of
Ala-1, an i to i12 interaction that often stabilizes Asn±
Pro-containing turns. Moreover, the side chain NH2
group donates hydrogen bonds to the carbonyl oxygens
of Leu-208 and Ile-211 in the 310 turn. The bound peptide
buries these carbonyls, which coordinate water mole-
cules in the unliganded structure. From the structure it
would seem likely that Asn is essential at this position,
as it is unique among amino acids in its ability to satisfy
all of the observed hydrogen bonding constraints.
The 310 turn and the C-terminal residues of helix a2
form the binding surface for the NPApY sequence. The
carbonyls in the 310 turn accept hydrogen bonds from
the peptide: the carbonyls of Leu-208 and Ile-211, from
Asn (pY23), as just described, and the carbonyl of Met-
209 from the terminal amide (and probably from the
main-chain amide of residue pY11 in the intact insulin
receptor). The restof thebinding surface is hydrophobic.
The clustering of three methionines is strikingÐMet-257
and Met-260 in the helix and Met-209 in the 310 turn
ring the ªNPXpYº-binding pocket (Figure 5A). Additional
hydrophobic interactions are contributed by methylene
groups from the side chains of Arg-258 and Ser-261,
which contact proline at pY22. Alanine appears to be
an optimal residue at the pY21 position. Larger hy-
drophobic side chains could not be accommodated in
the shallow pocket. Larger polar side chains, including
the glutamic acid found naturally at this position in the
insulin receptor, could turn and extend into solvent.
Phosphotyrosine Recognition
The pY side chain lies in an open pocket created by the
310 turn and residues at the end of strands b5 and b6.
An extensive network of hydrogen bond and ionic inter-
actions coordinate the phosphate oxygens (Figure 5B),
consistent with the observation that phosphorylation of
the tyrosine is necessary for detectable peptide binding
(Wolf et al., 1995). Two arginine residues line the binding
pocket. Arg-212 in strand b5 is in particularly intimate
contact with phosphotyrosine. Its aliphatic side chain
Figure 4. Structure and Coordination of the Insulin Receptor extends along the hydrophobic surface of the aromatic
Peptide ring, and its guanidinium group forms bidentate hydro-
(A) The bound insulin receptor peptide (IR) forms an additional strand gen bonds with phosphate oxygens. Glu-224 forms a
in the b sandwich. Bound water molecules are represented as long hydrogen bond with Arg-212, which may help orient
red crosses. The 1.8 AÊ 2Fo-Fc electron density map is contoured its guanidinium group for phosphotyrosine binding; in
at 1.5 s.
the unliganded structure Arg-212 is poorly ordered. The(B) Interactions between the insulin receptor and IRS-1. Ca trace
side chain of Arg-227 extends from the loop connectingand selected side chains of the PTB domain (yellow) and bound
peptide (tan) are shown. strands b6and b7and also donates twohydrogen bonds
Cell
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Figure 5. Recognition of the NPApY Se-
quence
(A) Detail of the NPApY b turn. Intrapeptide
and intermolecular hydrogen bonds and dis-
tances are shown in red. Three methionines
form a hydrophobic patch on the PTB do-
main, and contact the peptide.
(B) Phosphotyrosine is recognized primarily
by domain arginines 212 and 227. Ser-228
and Asn-210 coordinate water molecules (red
crosses) that make additional interactions
with the phosphate group.
to thephosphate oxygens. The main-chainamide of Arg- Shc domain shows that both share the core PH domain
fold (Zhou et al., 1995). The longer (z170 residue) Shc227 contributes a third hydrogen bond to the phosphate.
Two additional residues, Asn-210 and Ser-228, inter- domain has a short N-terminal helix not observed in our
structures and a large insertion between strands b1 andact with the phosphotyrosine by coordinating ªbridgedº
water molecules. The side chain of Asn-210 and the b2, which forms a helix and two long connecting loops
(Figure 1B). The two domains also share a commonbackbone amide of Ser-228 hydrogen bond with water
W1, which is also found in the apodomain structure. overall mode of peptide bindingÐthe general conforma-
tion and orientation of the phosphopeptide in complexThe hydroxyl group of Ser-228 coordinates a second
bridging water molecule (W2). with the Shc domain is the same as in the IRS-1 domain.
There is, however, a surprising divergence in themecha-
nism of phosphotyrosine recognition. None of the resi-Comparison with the Shc Domain
The phosphotyrosine-binding domains in Shc and dues that coordinate the phosphotyrosine appear to be
conserved between the two domains (Figures 1B andIRS-1 share little sequence homology, and these binding
domains were independently recognized and character- 3C). The Shc structure shows four residues likely to
interact with phosphotyrosine: Arg-67, Ser-151, Lys-ized. A search of sequence databases using the se-
quences of Shc and its close homolog Sck identified 169, and Arg-175. Site-directed mutations of Arg-67 and
Ser-151 both decrease binding to phosphopeptides,several possible PTB domains (Bork and Margolis,
1995), at least one of which was subsequently shown and mutation of Arg-175 to Gln or Lys completely elimi-
nates it (Zhou et al., 1995). None of these residues areto bind protein (Fiore et al., 1995). This search did not
identify the IRS-1 domain. Because of their functional identical to their counterparts in IRS-1. Arg-175, which
appears to be most critical for binding in Shc, corre-similarities, a structural relationship between the Shc
and IRS-1 domains has been suspected, but a previous sponds to proline 233 of IRS-1, while Arg-67 of Shc is
in a long insertion not present at all in IRS-1. Likewise,attempt to align IRS and Shc family PTB domains is not
consistent with the three-dimensional structures (Sun Arg-212, the residue we predict to be most crucial for
phosphotyrosine binding to the IRS-1 domain, corre-et al., 1995).
Comparison of the IRS-1 PTB domain with the recently sponds to Ser-151 in Shc. Of the four residues in the
Shc-binding site, Lys-169 has the closest homology indetermined nuclear magnetic resonance structure of the
Structure of the IRS-1 PTB Domain
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Figure 6. Schematic Representation of Inter-
actions between the Insulin Receptor Peptide
and the IRS-1 PTB Domain
Hydrogen bonds are shown as dashed lines,
hydrophobic interactions as thin dotted lines.
IRS-1, being in roughly the same position as Arg-227. does not stand out in comparison to the PH domains.
The C-terminal helix is longer in the liganded IRS-1 do-This divergence contrasts sharply with the conservation
main than in PH domains of known structure, but aof residues in the phosphotyrosine-binding pockets of
longer helix was not observed in the Shc PTB domain,SH2 domains (Waksman et al., 1992; Eck et al., 1993).
so this is not a defining feature of PTB domains. A con-The bB5 or ªFLVRESº arginine is found in all SH2 do-
served tryptophan present in the C-terminal helices ofmains. A second arginine at aA2 is found in all but a
the PH domains is not present in the IRS-1 PTB domain.few, and when absent, it does not appear to be replaced
However, the side chain of Trp-164, which arises fromby other basic residues (Lee et al., 1994; Eck et al.,
the b1 strand, occupies a similar position within the1996).
hydrophobic core of the IRS-1 domain.The extent to which the network of intra- and intermo-
The common fold and similarities we observe in hy-lecular interactions involving Asn-3are conserved in Shc
drophobic packing between the PH and PTB domains,is not yet clear. This residue is retained in all known
together with their related roles in signal transduction,PTB recognition sites, and given its observed role in
argue for a common evolutionary origin. The function ofstabilizing the conformation of the NPApY b turn and
PH domains is poorly understood, but at least a few ofin pairing with buried carbonyl oxygens in the 310 turn
these domains appear to mediate membrane localiza-in our structure, we would expect similar interactions to
tion by stereospecific binding to phosphoinositide headbe a feature of all PTB domains. The pY23 asparagine
groups. Structures of the spectrin and phospholipaseside chain appears tobe poorly defined by nuclear Over-
Cd PH domains have been determined in complex withhauser effects in the Shc structure. Interactions with the
inositol-(1,4,5)-trisphosphate (Ferguson et al., 1995; Hy-i12 amide nitrogen and with the turn connecting strands
voÈ nen et al., 1995). PH domains of known structure areb4 and b5 (the location of the 310 turn in IRS-1) are not
electrostatically polarizedÐthe end of the b sandwichdescribed, though the peptide adopts a grossly similar
opposite the C-terminal helix contains a cluster of basic
b-turn conformation. Interactions of the Asn side chain
residues and a net positive charge. This polarization hasNH2 with the aromatic ring and carbonyl of Phe-198 in been suggested to play a role in membrane attachment,
the C-terminal helix of Shc may replace those that we
and indeed the inositol trisphosphate in the PLCd struc-
observe in IRS-1.
ture binds in the center of this positively charged region
(Figure 3B). No such polarization is observed in the IRS
Comparison with PH Domains PTB domain, which is shown side-by-side with the PLCd
The structural similarity between PH and PTB domains PH domain in Figures 3A and 3B. Notably, the IRS-1
was first revealed in a comparison of the Shc structure PTB domain does not bind inositide polyphosphates
with PH domains (Zhou et al., 1995). The structural simi- with high affinity (Zhou et al., 1996; L. Rameh and L.
larity of the IRS-1 domain with PH domains is even Cantley, personal communication).
more striking. The a-carbon trace of the IRS-1 domain The comparison also makes clear that despite a simi-
is shown superimposed with the spectrin (HyvoÈ nen et larity in function (binding phosphate groups) and con-
al., 1995), phospholipase Cd (Ferguson et al., 1995), and served secondary structure, the locations of ligand-
dynamin (Ferguson et al., 1994) PH domain crystal struc- binding sites arequite different on PH and PTB domains.
tures in Figure 3D. The RMS deviation between z60 The use of a conserved, modular fold for a variety of
superimposed core residues in these PH domains and functions is a common theme in protein evolution, so it
IRS-1 is z1 AÊ , no greater than the deviation among the is not surprising to see divergence in function between
PH domains themselves. The structures diverge mark- PH and PTB domains. More remarkable is the diver-
edly in the length and conformation of loops connecting gence in the structure/function relationship between the
Shc and IRS-1 domains, because conserved structureelements of secondary structure, but the IRS domain
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and conserved function usually implies a closely related learn what ligands bind these domains and how recogni-
tion occurs.mechanism. Although IRS-1 and Shc bind similar ligands
with relatively high affinity and in the same general The domain architecture of IRS proteins facilitates
a segregation of distinct functions, as is common tomode, the two PTB domains apparently use divergent
sets of residues to accomplish this task. signaling molecules. The PTB domain is necessary for
efficient phosphorylation, probably by increasing effec-
tive concentrations of substrate at the kinase active siteComparison with SH2 Domains
and by allowing it to be phosphorylated at multiple sites.There isno structural relationship betweenSH2 domains
Flanking regions of IRS proteins may assist in this func-and PTB domains. Both domains specifically bind phos-
tion. The PH domain N-terminal to the PTB domain andphotyrosine-containing peptides, but they differ mark-
binding regions carboxy-terminal to itmay participate byedly in the way in which this specificity is achieved. In
binding adjacent phospholipids or peptide sequencesboth domains, two arginine residues coordinate phos-
(Gustafson et al., 1995; Myers et al., 1995; Voliovitch etphate oxygens, but the geometry of the interactions
al., 1995; He et al., 1996; Sawka-Verhelle et al., 1996).is distinct, because the arginines are presented by a
In this context, the PTB and PH domains, and possiblydifferent protein architecture. The hydrophobic interac-
additional domains in IRS proteins, may function to-tion of Arg-212 with the phosphotyrosine ring and the
gether to enhance affinity and specificity, much as hashydrogen bonds to the phosphate group are reminiscent
been seen previously with tandem SH2 and SH3 do-of the interaction of Lys bD6 seen in some Src family
mains (Eck et al., 1994, 1996; Hatada et al., 1995).SH2 structures (Waksman et al., 1992; Eck et al., 1993)
PTB and SH2 domains differ more dramatically in their
Experimental Procedures
recognition of sequences flanking phosphotyrosine.
Structural features of the SH2 domain allow marked Protein Expression and Binding Studies
BamHI and XhoI sites were introduced by polymerase chain reactionvariation in sequence specificity and sequence context.
immediately up- and downstream of the regions of the humanInsertions and sequence divergence in the EF and BG
IRS-1 cDNA (Araki et al., 1993) encoding residues 144±250, 144±278,loops of SH2 domains, and more modest substitutions
144±306, 144±316, 155±316, and 162±316. The DNA fragments werein the bD5 strand, allow for selectivity inbinding residues
subcloned into the corresponding sites in a pGEX-4T-1 (Pharmacia)
carboxy-terminal to the phosphotyrosine without pertur- plasmid and used to transform E. coli strain XL-1 blue (Stratagene).
bation of the SH2 domain fold (Eck et al. 1993; Waksman Following induction of protein expression with IPTG (isopropyl thio
b-D-galactoside) and cell collection and lysis, the protein was puri-et al. 1993; Lee et al. 1994; Nolte et al., 1996). In contrast,
fied by affinity chromatography using an immobilized glutathionePTB domains bind residues N-terminal to phosphotyro-
agarose column (Molecular Probes). For binding studies, GST fusionsine using elements of secondary structure Ð strand
proteins were eluted with 50 mM glutathione and dialyzed against
b5 and the C-terminal helix. Divergence in the peptide
100 mM ammonium bicarbonate containing 1.0 mM dithiothreitol
sequences recognized by PTB domains is therefore re- (DTT). Each protein was analyzed by direct binding with a radiola-
strained by the requirement for an asparagine-directed beled insulin receptor±derived peptide, [125I]LYASSNPApYLSASDV,
as described (TruÈ b et al., 1995; Wolf et al., 1995).turn and for an extended b strand. In SH2 domains,
backbone conformations of bound peptides vary, but
Crystallization of the IRS-1 PTBhydrogen bond interactions to the domain are main-
For crystallization, the GST/IRS-1 144±316 fusion protein bound totained by compensating changes in SH2 domain struc-
a glutathione column was cleaved with bovine thrombin (10 U/mL;
ture. These structural differences suggest a more limited Sigma) in 25 mM Tris±HCl buffer (pH 8.5) containing 150 mM NaCl
ability of the PTB domain to diverge in its recognition and 5 mM CaCl2. This procedure yields free IRS-1 144±267, owing
to cleavage at the engineered site in the vector and an additionalof peptide sequences, which may be consistent with
highly susceptible thrombin site at residue 267 within IRS-1. Twothe functions of PTB and SH2 domains. PTB domains
additional residues (Gly±Ser) at the amino terminus of the cleavedare found in substrates of receptor tyrosine kinases,
protein arise from the vector. Recovered protein was further purifiedwhile SH2 domains are typically associated with down-
using a Mono-Q HR10/10 ion-exchange column eluted with a linear
stream enzymes. Perhaps a more limited repertoire of NaCl gradient (0±200 mM in 180 mL at 2.0 mL/min) in 25 mM Tris±HCl
recognition motifs is suitable at this higher point in di- (pH 8.5) containing 1 mM DTT. The protein was concentrated in a
Centricon-10 device to 20 mg/ml. Apodomain crystals were grownverging pathways.
using the hanging drop vapor diffusion method by combining 2 mL
of protein solution (3 mg/ml, 25 mM Tris±HCl [pH 8.5], 0.1 M NaCl,
Implications 10 mM DTT) with 2 mL of well solution (1.7 M ammonium sulfate,
0.1 M sodium citrate [pH 5.6], 0.3 M NaCl, 20 mM DTT). The ortho-Three-dimensional structures are now known for two
rhombic crystals (P212121 a 5 35.07 AÊ , b 5 50.71 AÊ , c 5 56.26 AÊ )PTB domains. Although these domains share the gen-
grew to about 0.15 3 0.15 3 0.2 mm over several days at 228C.eral PH domain fold, their mechanisms for phosphopep-
Crystals were harvested into a synthetic mother liquor containingtide recognition are distinct. High resolution, liganded
2.0 M ammonium sulfate, 0.3 M NaCl, 0.1 M sodium citrate [pH 5.6].
structures for the PLCd and spectrin PH domains have Heavy atom derivatives were prepared by soaking crystals for 1±2
been determined, as well. Inositide polyphosphate days in this harvest buffer plus 0.2 mM methyl mercury nitrate, 0.25
mM mercuric chloride, or 1.0 mM potassium platinum tetrachloride.groups bind at different sites on the two PH domains,
Crystals of the PTB domain in complex with the insulin receptorat the base of the b sandwich and distant from the
peptide were grown by the same method using 2 mL protein solutionsurfaces used by thePTB domains for phosphate recog-
(10 mg/ml, 1 mM IR peptide, 25 mM Tris±HCl [pH 8.5], 0.1 M NaCl,nition. Thus the PH domain fold appears to represent a
10 mM DTT) with 2 mL of well solution (1.7 M ammonium sulfate,
versatile scaffold for achieving diverse functions. There 0.1 M NaCl, 2% glycerol, 0.1 M PIPES [pH 6.5], 20 mM DTT). The
are nearly 90 related domains identified by sequence insulin receptor phosphopeptide acetyl-LYASSNPApY-NH2 was
synthesized following an Na-Fmoc protecting group strategy andhomology, and more likely exist. It will be interesting to
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Table 1. Structure Determination and Refinement
Summary of MIR Phase Determination
Phasing Power
Resolution Completeness Isomorphous Number
Derivative Limit (%) Rmerge Difference Acentric Centric of Sites
Native 1.95 98.1 4.3 2 2 2 2
MeHgNO3 2.5 86.6 5.9 30.5 1.28 0.96 1
MeHgNO3 2.35 98.5 5.1 20.3 1.32 1.05 1
HgCl2 2.35 88.4 6.8 29.8 0.76 0.56 1
K2PtCl4 2.5 96.4 5.1 25.3 0.65 0.54 1
K2PtCl4 2.5 99.1 6.5 21.6 0.66 0.56 1
Data Collection and Refinement Statistics
Complex Unliganded
Space group P422 P212121
Unit cell a 5 68.37, c 5 57.52 a 5 35.07, b 5 50.71, c 5 56.26
Reflections
Observed/unique 72,265/12,453 32,748/7589
Rmerge (%) 6.57 4.29
Completeness (%) 94.9 98.2
I/sI (last shell) 2.93 6.23
Refinement
Resolution 20.0±1.8 AÊ 20.0±1.95 AÊ
Rcryst/Rfree (I . 2s) 17.1/20.6 18.6/25.2
Rcryst/Rfree (all data) 19.6/23.1 20.3/27.3
RMS deviation
Bond length (AÊ ) 0.008 0.011
Bond angles (deg) 1.17 1.1
purified by high pressure liquid chromatography (Piccione et al., resolution data in refinement. Ordered water molecules were posi-
tioned with the aid of the program ARP (Lamzin and Wilson, 1993).1993). Tetragonal crystals (P422; a 5 b 5 68.37 AÊ , c 5 57.52 AÊ )
grew to about 0.1 3 0.1 3 0.3 mm over several days at 228C. The final model, including residues 161 to 261 and 119 solvent
molecules, was refined to an R value of 18.6% (Rfree 5 25.2%) with
good stereochemistry (Table 1).Data Collection and Structure Determination
All diffraction data were recorded at room temperature using an 18 The structure of the PTB domain/peptide complex was deter-
mined by molecular replacement using the partially refined apodo-or 30 cm MarResearch image plate scanner on an Elliot GX-13
rotating anode source with double-focusing mirror optics. Oscilla- main structure as a search model. Unambiguous rotation and trans-
lation solutions were obtained using data between 8.0 and 3.0 AÊtion images (18) were processed using a Mar version of the program
XDS (Kabsch, 1988). Diffraction intensities were scaled and merged resolution with the program AMoRe (Navaza, 1992). After rigid body
and simulated annealing refinement of the properly positionedwith the program MARSCALE (Kabsch, 1988). For heavy atom deriv-
ative data sets, local scaling to the Wilson-scaled native data was search model, 2Fo-Fc maps revealed clearly interpretable electron
density for the entire phosphopeptide ligand and for most of thecarried out with MAXSCALE (M. Rould).
The CCP4 program suite (Collaborative Computational Project 20 protein side chains not present in the search model. As in the
unliganded structure, no electron density was observed for the 19Number 4, 1994) was employed for structure determination. Heavy
atom occupancies were initially refined with the program HEAVY residues amino-terminal to Lys-161 (144±160). Ordered water mole-
cules were positioned with the aid of the program ARP. The structure(Terwilliger and Eisenberg, 1988). Final phasing calculations were
carried out with MLPHARE (Otwinowski, 1991). The structure of the was refined using simulated annealing and positional refinement
protocols in X-plor to a crystallographic R value of 17.1% (Rfree 5apodomain was determined by multiple isomorphous replacement
(MIR) using methyl mercury nitrate, mercuric chloride, and potas- 20.6%). The Rfree value for the complex is significantly lower than
that for the unliganded structure, which is likely attributable to thesium platinum tetrachloride derivatives. Inclusion of two methyl mer-
cury and two platinum derivative data sets improved the quality of lower Wilson temperature factor for data recorded from crystals of
the complex. A solvent correction model allowed inclusion of lowthe phases even though the duplicate data sets had identical sites
and similar occupancy. Anomalous data from all derivatives were resolution data in refinement. Isotropic temperature factors were
refined with tight restraints. The final model included residues 161±included in the phase calculations. The anomalous signal from the
methyl mercury derivative was particularly strong and was used 265 of IRS-1, the 9-residue peptide, and 120 water molecules. Data
collection and refinement statistics are summarized in Table 1.to determine the hand of the heavy atom constellation. Phasing
statistics are presented in Table 1. The clarity of the electron density
map was improved with real space density modification using the Acknowledgments
program DM (Cowtan, 1994). Experimental phases were extended
from 2.7 to 2.0 AÊ with solvent flattening, histogram matching, and The authors thank Masaya Miyazaki, Lone Hansen, and Gert Wolf
for assistance in peptide synthesis, obtaining PTB domain proteins,Sayre's equation algorithms in DM. The complete protein main chain
and z80% of the side chains were readily constructed in the modi- and assessing PTB domain function, respectively; Kazuyasu Saka-
guchi (National Cancer Institute/National Institutes of Health) forfied MIR map using the program O (Jones et al., 1989). A map
calculated with model phases after an initial round of crystallo- electrospray mass spectrometric analyses; and Andrea Musacchio
for helpfuldiscussions. Special thanksare given to Stephen Harrisongraphic refinement allowed interpretation of the remaining side
chains. The structure was refined with iterative cycles of manual (Howard Hughes Medical Institute, Children's Hospital, Boston) for
continued support and advice given throughout this project. Finan-fitting and simulated annealing and positional refinement in X-plor
(Brunger, 1992). Isotropic temperature factors were refined. Incor- cial support for these studies was provided by grants from the
Lucille P. Markey Charitable Trust to Children's Hospital (M. J. E.),poration of a solvent correction model allowed inclusion of low
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